Double maintains 1 strategies that include PHAT - Phathom Pharmaceuticals, Inc.
Current Value
$8.791 Year Return
Current Value
$8.791 Year Return
Yahoo
Phathom Pharmaceuticals, Inc. ( NASDAQ:PHAT ) is possibly approaching a major achievement in its business, so we would...
SeekingAlpha
Phathom Pharmaceuticals: Potential Blockbuster Gastric Acid-Reducing Drug With New Mechanism
Yahoo
FLORHAM PARK, N.J., June 23, 2025 (GLOBE NEWSWIRE) -- Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a biopharmaceutical company focused on developing and commercializing novel treatments for gastrointestinal (GI) diseases, today announced that, in connection with the appointment of Anne Marie Cook as Chief Legal Officer and Corporate Secretary, the Company’s Board of Directors has approved the grant of inducement awards. On June 23, 2025, the Compensation Committee of the Company’s Board of Dire
Yahoo
FLORHAM PARK, N.J., June 23, 2025 (GLOBE NEWSWIRE) -- Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a biopharmaceutical company focused on developing and commercializing novel treatments for gastrointestinal (GI) diseases, today announced the appointment of Anne Marie Cook, J.D., as Chief Legal Officer and Corporate Secretary. Ms. Cook is an accomplished pharmaceutical legal executive with a proven track record advising pharmaceutical companies and broad expertise in corporate governance, commer
Finnhub
FLORHAM PARK - Phathom Pharmaceuticals, Inc. , a biopharmaceutical company focused on developing and commercializing novel treatments for gastrointestinal diseases, announced that the U.S. Food and...
Yahoo
FLORHAM PARK, N.J., June 16, 2025 (GLOBE NEWSWIRE) -- Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a biopharmaceutical company focused on developing and commercializing novel treatments for gastrointestinal (GI) diseases, today announced that the U.S. Food and Drug Administration (FDA) has updated the Approved Drug Products with Therapeutic Equivalence Evaluations (the “Orange Book”) to accurately reflect the full 10-year period of non-patent New Chemical Entity (NCE) exclusivity for VOQUEZNA®
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
PM | 0.01% | $273.81B | +73.45% | 3.06% |
SAFT | -0.03% | $1.14B | +1.96% | 4.71% |
NTES | -0.04% | $84.57B | +38.66% | 2.08% |
OCFT | -0.06% | $267.49M | +332.74% | 0.00% |
PNW | -0.10% | $10.77B | +19.40% | 3.95% |
SCHL | -0.11% | $584.62M | -37.25% | 3.67% |
CQP | 0.12% | $27.02B | +12.31% | 5.88% |
CMG | 0.13% | $76.49B | -7.81% | 0.00% |
AZO | 0.13% | $61.65B | +29.54% | 0.00% |
CCEC | -0.17% | $1.02B | +3.91% | 2.58% |
IMNN | 0.18% | $16.26M | -34.16% | 0.00% |
TEF | -0.18% | $30.08B | +25.41% | 6.16% |
NPKI | -0.18% | $738.73M | +9.11% | 0.00% |
DCGO | -0.20% | $155.59M | -46.60% | 0.00% |
BKH | 0.21% | $4.10B | +4.00% | 4.67% |
STZ | -0.21% | $30.76B | -30.55% | 2.33% |
FDP | 0.22% | $1.59B | +52.62% | 3.31% |
RTX | 0.23% | $193.07B | +43.46% | 1.77% |
UUU | 0.26% | $7.17M | +101.30% | 0.00% |
CXM | 0.28% | $2.23B | -14.33% | 0.00% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
BTAL | -21.79% | $296.22M | 1.43% |
VIXY | -19.32% | $164.54M | 0.85% |
TAIL | -17.84% | $99.63M | 0.59% |
IVOL | -12.93% | $347.03M | 1.02% |
SHYM | -11.94% | $357.13M | 0.35% |
SCHO | -9.89% | $11.03B | 0.03% |
FMHI | -8.26% | $754.85M | 0.7% |
TPMN | -7.49% | $30.70M | 0.65% |
LGOV | -7.28% | $678.86M | 0.67% |
FTSD | -7.28% | $231.81M | 0.25% |
FLMI | -7.24% | $725.99M | 0.3% |
USDU | -6.79% | $162.43M | 0.5% |
IBMS | -6.45% | $89.64M | 0.18% |
FMB | -6.43% | $1.90B | 0.65% |
BSMW | -6.26% | $107.45M | 0.18% |
DFNM | -6.06% | $1.57B | 0.17% |
MLN | -6.06% | $541.74M | 0.24% |
BUXX | -5.95% | $315.18M | 0.25% |
TAXF | -5.84% | $489.34M | 0.29% |
PZA | -5.74% | $2.84B | 0.28% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
JBND | 0.02% | $2.32B | 0.25% |
FMF | -0.03% | $158.70M | 0.95% |
UBND | -0.04% | $1.02B | 0.4% |
LMBS | -0.05% | $5.11B | 0.64% |
MUNI | 0.06% | $2.01B | 0.35% |
IBMP | 0.07% | $553.65M | 0.18% |
TOTL | 0.12% | $3.84B | 0.55% |
SPMB | -0.12% | $6.16B | 0.04% |
TIP | 0.12% | $13.96B | 0.18% |
TLH | -0.22% | $11.52B | 0.15% |
MUB | 0.23% | $38.64B | 0.05% |
BAB | 0.28% | $933.45M | 0.28% |
SCHQ | -0.33% | $758.74M | 0.03% |
SUB | 0.35% | $9.91B | 0.07% |
CGSD | -0.37% | $1.32B | 0.25% |
MINO | -0.46% | $320.08M | 0.39% |
VMBS | -0.46% | $14.48B | 0.03% |
CMF | 0.50% | $3.59B | 0.08% |
TFI | -0.52% | $3.22B | 0.23% |
SPSK | 0.53% | $321.02M | 0.5% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
GIII | -18.16% | $1.01B | -11.79% | 0.00% |
BTCT | -17.37% | $25.56M | +61.14% | 0.00% |
LULU | -15.55% | $29.52B | -17.99% | 0.00% |
TR | -13.36% | $2.57B | +22.68% | 1.02% |
ABM | -12.71% | $3.01B | -4.26% | 2.05% |
SLE | -11.99% | $4.57M | -84.82% | 0.00% |
KR | -11.20% | $46.43B | +38.38% | 1.85% |
DOCU | -11.04% | $15.59B | +42.53% | 0.00% |
KMB | -9.86% | $43.92B | -3.75% | 3.75% |
BRZE | -9.81% | $3.13B | -28.76% | 0.00% |
GO | -9.65% | $1.28B | -39.16% | 0.00% |
MO | -9.55% | $99.67B | +28.77% | 6.90% |
ED | -8.90% | $36.00B | +12.64% | 3.34% |
TSN | -8.47% | $20.06B | +1.50% | 3.46% |
VSTA | -6.64% | $344.07M | +39.29% | 0.00% |
FTS | -6.60% | $23.62B | +20.13% | 3.70% |
HSY | -6.56% | $35.88B | -3.63% | 3.10% |
ACI | -6.41% | $12.40B | +10.61% | 2.47% |
CNP | -6.37% | $23.35B | +17.94% | 2.36% |
WOOF | -6.34% | $823.01M | -6.94% | 0.00% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
ARKK | 30.12% | $6.85B | 0.75% |
XPH | 30.07% | $147.96M | 0.35% |
XBI | 29.94% | $4.82B | 0.35% |
GNOM | 29.23% | $44.57M | 0.5% |
ARKG | 28.30% | $1.02B | 0.75% |
IBB | 27.68% | $5.26B | 0.45% |
PINK | 27.14% | $130.57M | 0.5% |
PTH | 27.13% | $100.85M | 0.6% |
ARKW | 26.87% | $2.10B | 0.82% |
CPRJ | 26.74% | $48.26M | 0.69% |
IWC | 26.50% | $818.14M | 0.6% |
ARKF | 26.06% | $1.20B | 0.75% |
KJUL | 25.39% | $119.50M | 0.79% |
PBE | 25.09% | $223.19M | 0.58% |
BBH | 24.54% | $330.62M | 0.35% |
FBT | 24.12% | $1.01B | 0.54% |
IWMY | 24.10% | $119.32M | 1.02% |
IWO | 24.01% | $11.60B | 0.24% |
UJUL | 23.45% | $136.78M | 0.79% |
VHT | 23.37% | $15.35B | 0.09% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
URGN | 42.53% | $597.55M | -13.66% | 0.00% |
MANU | 39.49% | $2.98B | +8.25% | 0.00% |
ACIU | 38.20% | $199.87M | -46.98% | 0.00% |
RGNX | 36.18% | $434.35M | -20.33% | 0.00% |
RXRX | 34.24% | $2.12B | -29.12% | 0.00% |
CELC | 32.83% | $493.78M | -20.05% | 0.00% |
GBIO | 32.32% | $22.65M | -86.15% | 0.00% |
PDSB | 32.00% | $58.05M | -57.81% | 0.00% |
CRBU | 31.89% | $127.42M | -14.38% | 0.00% |
ATXS | 30.98% | $323.37M | -36.33% | 0.00% |
ACET | 30.54% | $50.78M | -43.67% | 0.00% |
GPRO | 30.43% | $116.59M | -47.14% | 0.00% |
BLFS | 29.82% | $1.08B | +13.58% | 0.00% |
IDT | 29.75% | $1.76B | +95.47% | 0.31% |
COGT | 29.66% | $843.67M | -11.36% | 0.00% |
CRSP | 29.53% | $4.46B | -4.14% | 0.00% |
IRON | 28.90% | $1.84B | +19.67% | 0.00% |
SYRE | 28.70% | $935.48M | -39.83% | 0.00% |
MGNX | 28.33% | $87.06M | -67.14% | 0.00% |
CHGG | 28.26% | $149.20M | -51.39% | 0.00% |